Luminex Corp – Strategy, SWOT and Corporate Finance Report

Luminex Corp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP, xTAG and MultiCode. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

Scope

Detailed information on Luminex Corp required for business and competitor intelligence needs

A study of the major internal and external factors affecting Luminex Corp in the form of a SWOT analysis

An in-depth view of the business model of Luminex Corp including a breakdown and examination of key business segments

News about Luminex Corp, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Luminex Corp and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Luminex Corp as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Luminex Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Illumina Inc

Roche Diagnostics International Ltd

Meso Scale Diagnostics LLC

Sequenom Inc

BioFire Diagnostics LLC

Siemens Medical Solutions USA Inc

Cepheid

Alere Inc

Qiagen NV

Hologic Inc

Becton Dickinson and Co

Affymetrix, Inc.

Life Technologies Corp

Meridian Bioscience Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Luminex Corp - Key Facts

Luminex Corp - Key Employees

Luminex Corp - Key Employee Biographies

Luminex Corp - Major Products and Services

Luminex Corp - History

Luminex Corp - Company Statement

Luminex Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Luminex Corp - Business Description

Business Segment: Assay

Overview

Performance

Business Segment: Consumables

Overview

Performance

Business Segment: Other

Overview

Performance

Business Segment: Royalty

Overview

Performance

Business Segment: Service

Overview

Performance

Business Segment: System

Overview

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Canada

Performance

Geographical Segment: Domestic

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Other Regions

Performance

R&D Overview

Luminex Corp - Corporate Strategy

Luminex Corp - SWOT Analysis

SWOT Analysis - Overview

Luminex Corp - Strengths

Luminex Corp - Weaknesses

Luminex Corp - Opportunities

Luminex Corp - Threats

Luminex Corp - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Luminex Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Luminex Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Luminex Corp, Recent Deals Summary

Section 5 Company’s Recent Developments

May 06, 2019: Luminex reports first quarter 2019 financial results

Apr 17, 2019: BHP announces operational review for nine months ended March 31, 2019

Feb 04, 2019: Luminex reports fourth quarter and full-year 2018 financial results

Jan 16, 2019: AllerGenis granted rights to develop and market its precision food allergy diagnostic using Luminex xMAP technology

Jan 07, 2019: Luminex announces preliminary revenue for the fourth quarter and full year 2018

Nov 05, 2018: Luminex reports third quarter 2018 financial results

Oct 19, 2018: Luminex to buy MilliporeSigma's flow cytometry portfolio

Aug 06, 2018: Luminex reports second quarter 2018 financial results

May 07, 2018: Luminex Announces First Quarter 2018 Financial Results

Feb 12, 2018: Luminex Reports Fourth Quarter and Full-Year 2017 Financial Results

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Luminex Corp, Key Facts

Luminex Corp, Key Employees

Luminex Corp, Key Employee Biographies

Luminex Corp, Major Products and Services

Luminex Corp, History

Luminex Corp, Other Locations

Luminex Corp, Subsidiaries

Luminex Corp, Key Competitors

Luminex Corp, Ratios based on current share price

Luminex Corp, Annual Ratios

Luminex Corp, Annual Ratios (Cont…1)

Luminex Corp, Annual Ratios (Cont…2)

Luminex Corp, Interim Ratios

Luminex Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Luminex Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Luminex Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Luminex Corp, Performance Chart (2014 – 2018)

Luminex Corp, Ratio Charts

Luminex Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Luminex Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports